托法替布联合低剂量糖皮质激素治疗增殖型天疱疮1例

doi:10.35541/cjd.20240114

Chinese Journal of Dermatology ›› 2026, e20240114.doi: 10.35541/cjd.20240114

• Case Reports • Previous Articles Next Articles

A case of pemphigus vegetans treated with tofacitinib combined with low-dose glucocorticoids

Zheng Yuanyuan¹, Wang Anqi¹, Guan Xin¹, Li Dongming¹, Su Jing², Wang Wenhui¹

¹Department of Dermatology, Peking University Third Hospital, Beijing 100191, China;²Department of Pathology, Peking University Third Hospital, Beijing 100191, China

Received:2024-02-29 Revised:2026-04-30 Online:2026-03-11 Published:2026-06-22
Contact: Wang Wenhui E-mail:wwh0608@126.com
Supported by:
Beijing Municipal Natural Science Foundation（7232197）

Abstract

Zheng Yuanyuan, Wang Anqi, Guan Xin, Li Dongming, Su Jing, Wang Wenhui. A case of pemphigus vegetans treated with tofacitinib combined with low-dose glucocorticoids[J]. Chinese Journal of Dermatology,2026,e20240114. doi:10.35541/cjd.20240114

References ［8］

［1］	Zaraa I, Sellami A, Bouguerra C, et al. Pemphigus vegetans: a clinical, histological, immunopathological and prognostic study［J］. J Eur Acad Dermatol Venereol, 2011,25（10）:1160⁃1167. DOI: 10.1111/j. 1468⁃3083.2010.03939.x.
［2］	中国医师协会皮肤科医师分会, 中华医学会皮肤性病学分会治疗学组, 中国医疗保健国际交流促进会皮肤医学分会, 等. 中国天疱疮诊疗指南（2024版）［J］. 中华皮肤科杂志, 2024,57（10）:873⁃886. DOI: 10.35541/cjd.20240222.
［3］	Huang D, Zhang Y, Kong L, et al. Janus kinase inhibitors in autoimmune bullous diseases［J］. Front Immunol, 2023,14:1220887. DOI: 10.3389/fimmu.2023.1220887.
［4］	Juczynska K, Wozniacka A, Waszczykowska E, et al. Expression of JAK3, STAT2, STAT4, and STAT6 in pemphigus vulgaris［J］. Immunol Res, 2020,68（2）:97⁃103. DOI: 10.1007/s12026⁃020⁃09122⁃y.
［5］	Tavakolpour S. Tofacitinib as the potent treatment for refractory pemphigus: a possible alternative treatment for pemphigus［J］. Dermatol Ther, 2018,31（5）:e12696. DOI: 10.1111/dth.12696.
［6］	Fan B, Wang M. Tofacitinib in recalcitrant bullous pemphigoid: a report of seven cases［J］. Br J Dermatol, 2023,188（3）:432⁃434. DOI: 10.1093/bjd/ljac078.
［7］	Fan B, Wang M. Treatment of recurrent epidermolysis bullosa acquisita with tofacitinib［J］. JAMA Dermatol, 2023,159（3）:342⁃344. DOI: 10.1001/jamadermatol.2022.6250.
［8］	Kim D, Kobayashi T, Voisin B, et al. Targeted therapy guided by single⁃cell transcriptomic analysis in drug⁃induced hypersensitivity syndrome: a case report［J］. Nat Med, 2020,26（2）:236⁃243. DOI: 10.1038/s41591⁃019⁃0733⁃7.

A case of pemphigus vegetans treated with tofacitinib combined with low-dose glucocorticoids

PDF

PDF (Mobile)

Knowledge

Abstract

Cite this article

share this article

References ［8］

Related Articles 0

Metrics

Comments

Recommended 10